Clinical Trials Directory

Trials / Completed

CompletedNCT02770313

Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to determine how effective repeated fasting over 26 weeks (6 months) is at improving risk parameters that are surrogate endpoints for cardiovascular diseases, metabolic dysregulation and cognitive impairments. Subjects will be randomized 1:1 to water-only fasting or to their ad libitum usual diet, with randomization performed within strata based on fasting history (≤180 hours or 181-720 hours of total fasting for \>12 consecutive hours per episode in the previous two years). Subjects will be assessed at 4, 13 and 26 weeks following randomization.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntermittent FastingSubjects allocated to the fasting arm will undergo a fasting regimen of twice-per-week 24-hour fasting on non-consecutive days during the first 4 weeks of the study, then once-per-week 24-hour fasting during the rest of the study (22 weeks).

Timeline

Start date
2016-10-01
Primary completion
2020-02-19
Completion
2020-02-19
First posted
2016-05-12
Last updated
2020-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02770313. Inclusion in this directory is not an endorsement.

Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction (NCT02770313) · Clinical Trials Directory